Trademark Attorney / Law Firm

CRYSTAL S. WILDEMAN – Trademark Portfolio

CRYSTAL S. WILDEMAN has filed 4 trademarks with the United States Patent and Trademark Office (USPTO). Filing records are from 2017. Of these filings, 1 is currently registered. The portfolio covers 4 Nice Classification classes, with the highest concentration in Class 35 (Advertising & Business, 1 filings) and Class 41 (Education & Entertainment, 1 filings).

4 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

CRYSTAL S. WILDEMAN's trademark practice covers 4 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

43
Hotels & Restaurants (1 filing)

Services for providing food and drink; temporary accommodation

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademark applications has CRYSTAL S. WILDEMAN filed?

CRYSTAL S. WILDEMAN has filed 4 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 3 cancelled.

What trademark classes does CRYSTAL S. WILDEMAN specialize in?

CRYSTAL S. WILDEMAN has filed trademarks across 4 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 43 (Hotels & Restaurants), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What is CRYSTAL S. WILDEMAN's trademark registration success rate?

CRYSTAL S. WILDEMAN has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.